rimantadine has been researched along with Papillomavirus Infections in 2 studies
Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.
Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Miyauchi, S | 1 |
Sanders, PD | 1 |
Guram, K | 1 |
Kim, SS | 1 |
Paolini, F | 1 |
Venuti, A | 1 |
Cohen, EEW | 1 |
Gutkind, JS | 1 |
Califano, JA | 1 |
Sharabi, AB | 1 |
Wetherill, LF | 1 |
Wasson, CW | 1 |
Swinscoe, G | 1 |
Kealy, D | 1 |
Foster, R | 1 |
Griffin, S | 1 |
Macdonald, A | 1 |
2 other studies available for rimantadine and Papillomavirus Infections
Article | Year |
---|---|
HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Topics: Adolescent; Adult; Aged; Animals; Antigen Presentation; Antineoplastic Agents, Immunological; Antine | 2020 |
Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5.
Topics: Antiviral Agents; Cell Line; Cyclin B1; Humans; Imino Sugars; Ion Channels; Keratinocytes; MAP Kinas | 2018 |